High_JJ Circulating_JJ Frequencies_NNS of_IN Tumor_NP Necrosis_NP Factor_NP Alpha-_NP and_CC Interleukin-2-Secreting_NP Human_NP T-Lymphotropic_NP Virus_NP Type_NP 1_CD (HTLV-1)-Specific_JJ CD4+_NP T_NN Cells_NP in_IN Patients_NPS with_IN HTLV-1-Associated_NP Neurological_NP Disease_NP Significantly_NP higher_JJR frequencies_NNS of_IN tumor_NN necrosis_NN factor_NN alpha-_NN and_CC interleukin-2-secreting_VBG human_JJ T-lymphotropic_JJ virus_NN type_NN 1_CD (HTLV-1)-specific_JJ CD4+_NP T_NN cells_NNS were_VBD present_JJ in_IN the_DT peripheral_JJ blood_NN mononuclear_JJ cells_NNS of_IN HTLV-1-associated_JJ myelopathy/tropical_JJ spastic_JJ paraparesis_NN (_( HAM/TSP_NP )_) patients_NNS than_IN in_IN those_DT of_IN asymptomatic_JJ carriers_NNS with_IN similar_JJ provirus_NN loads_NNS ._SENT The_DT data_NNS suggest_VBP that_IN HTLV-1-specific_NP CD4+_NP T_NN cells_NNS play_VBP a_DT role_NN in_IN the_DT pathogenesis_NN of_IN HAM/TSP_NP ._SENT HTLV-1_NP (_( human_JJ T-lymphotropic_JJ virus_NN type_NN 1_CD )_) is_VBZ the_DT causative_JJ agent_NN of_IN adult_JJ T-cell_NN leukemia/lymphoma_NN and_CC HTLV-1-associated_JJ myelopathy/tropical_JJ spastic_JJ paraparesis_NN (_( HAM/TSP_NP )_) and_CC is_VBZ distantly_RB related_VBN to_TO human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) ._SENT However_RB ,_, whereas_IN infection_NN with_IN HIV-1_JJ results_NNS in_IN disease_NN in_IN almost_RB all_DT of_IN those_DT infected_JJ ,_, infection_NN with_IN HTLV-1_NP usually_RB results_VBZ in_IN persistent_JJ asymptomatic_JJ carriage_NN ;_: less_JJR than_IN 7_CD %_NN will_MD develop_VB either_DT adult_JJ T-cell_NN leukemia/lymphoma_NN or_CC HAM/TSP_NP ._SENT The_DT cause_NN of_IN these_DT differing_VBG outcomes_NNS is_VBZ unknown_JJ ._SENT Despite_IN the_DT fact_NN that_IN HTLV-1_NP causes_VBZ disabling_VBG and_CC fatal_JJ diseases_NNS ,_, there_EX is_VBZ no_DT vaccine_NN and_CC no_DT satisfactory_JJ treatment_NN for_IN either_CC the_DT malignancy_NN or_CC the_DT inflammatory_JJ diseases_NNS ._SENT HAM/TSP_NP is_VBZ characterized_VBN by_IN a_DT chronic_JJ ,_, progressive_JJ ,_, inflammatory_JJ ,_, demyelinating_VBG myelopathy_NN that_WDT resembles_VBZ progressive_JJ spinal_JJ forms_NNS of_IN multiple_JJ sclerosis_NN ._SENT The_DT pathogenesis_NN of_IN this_DT disease_NN is_VBZ unclear_JJ but_CC is_VBZ thought_VBN to_TO involve_VB the_DT host_NN 's_POS immune_JJ response_NN to_TO the_DT virus_NN ._SENT The_DT lesions_NNS in_IN the_DT central_JJ nervous_JJ system_NN (_( CNS_NP )_) contain_VBP infiltrates_NNS of_IN inflammatory_JJ cells_NNS ._SENT Until_IN now_RB ,_, most_JJS work_NN on_IN the_DT cell-mediated_JJ immune_JJ response_NN to_TO HTLV-1_NP has_VBZ focused_VBN on_IN the_DT cytotoxic_JJ T-lymphocyte_NP (_( CTL_NP )_) response_NN ._SENT CTL_NN responses_NNS are_VBP critical_JJ to_TO clearing_VBG virus_NN infections_NNS by_IN the_DT specific_JJ lysis_NN of_IN infected_JJ cells_NNS and_CC secretion_NN of_IN antiviral_JJ cytokines_NNS such_JJ as_IN gamma_NN interferon_NN (_( IFN-gamma_NP )_) and_CC tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ._SENT In_IN addition_NN to_TO CTLs_NP ,_, acquired_VBN immunity_NN is_VBZ also_RB critically_RB dependent_JJ on_IN the_DT generation_NN of_IN virus-specific_JJ CD4+_NP T-helper_NN responses_NNS ._SENT By_IN secreting_VBG cytokines_NNS upon_IN recognition_NN of_IN cognate_JJ antigen_NN ,_, the_DT CD4+_NP T-helper_NN cell_NN is_VBZ involved_VBN in_IN the_DT coordination_NN of_IN the_DT immune_JJ response_NN to_TO the_DT invading_VBG pathogen_NN ._SENT Activated_VBN T-helper_NN cells_NNS can_MD produce_VB interleukin-2_JJ (_( IL-2_NP )_) and_CC IFN-gamma_NP ,_, which_WDT augment_VBP CTL_NP effector_NN functions_NNS (_( Th1_NP )_) ,_, and_CC IL-4_NN ,_, IL-5_NP ,_, IL-6_NP ,_, and_CC IL-10_NP ,_, which_WDT promote_VBP B-cell_NN and_CC antibody_NN responses_NNS (_( Th2_NP )_) ._SENT T-helper_NN cells_NNS can_MD also_RB activate_VB professional_JJ antigen-presenting_NN cells_NNS by_IN secretion_NN of_IN cytokines_NNS or_CC upregulation_NN of_IN CD40L_NP on_IN the_DT cell_NN surface_NN ._SENT Several_JJ observations_NNS on_IN HTLV-1_NP demonstrate_VBP the_DT potential_JJ importance_NN of_IN CD4+_NP T_NN cells_NNS in_IN the_DT cellular_JJ immune_JJ response_NN to_TO the_DT virus_NN ._SENT (_( i_NP )_) CD4+_NP T_NN cells_NNS are_VBP the_DT main_JJ subset_NN of_IN cells_NNS infected_VBN with_IN HTLV-1_NP in_IN vivo_RB ._SENT (_( ii_NP )_) Infected_NP CD4+_NP T_NN cells_NNS spontaneously_RB secrete_VBP proinflammatory_JJ ,_, neurotoxic_JJ cytokines_NNS such_JJ as_IN TNF-alpha_NP and_CC IFN-gamma_NP ,_, and_CC high_JJ levels_NNS of_IN these_DT cytokines_NNS have_VBP been_VBN demonstrated_VBN in_IN the_DT serum_NN ,_, cerebrospinal_JJ fluid_NN ,_, and_CC spinal_JJ cord_NN lesions_NNS of_IN HAM/TSP_NP patients_NNS ._SENT (_( iii_NP )_) HTLV-1_NP infection_NN in_IN CD4+_NP T_NN cells_NNS can_MD impair_VB T-helper_NN function_NN ._SENT (_( iv_NP )_) CD4+_NP CD45RO+_NP T_NN cells_NNS are_VBP the_DT predominant_JJ infiltrating_VBG subset_NN (_( 65_CD %_NN )_) of_IN total_JJ CD3+_NP T_NN cells_NNS in_IN newer_JJR CNS_NP lesions_NNS of_IN HAM/TSP_NP patients_NNS ._SENT Others_NNS have_VBP also_RB detected_VBN more_RBR CD4+_JJ T_NN cells_NNS in_IN the_DT CNS_NP lesions_NNS of_IN HAM/TSP_NP patients_NNS with_IN a_DT short_JJ history_NN of_IN disease_NN than_IN in_IN patients_NNS with_IN a_DT long_JJ history_NN of_IN disease_NN (_( when_WRB CD8+_NP T_NN cells_NNS predominate_VBP )_) ._SENT We_PP recently_RB reported_VBD that_IN IFN-gamma-secreting_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS were_VBD significantly_RB more_RBR frequent_JJ in_IN HAM/TSP_NP patients_NNS than_IN in_IN asymptomatic_JJ carriers_NNS (_( ACs_NP )_) ._SENT This_DT observation_NN suggested_VBD that_IN these_DT HTLV-1-specific_NP CD4+_NP T_NN cells_NNS could_MD be_VB involved_VBN in_IN the_DT initiation_NN and_CC pathogenesis_NN of_IN HAM/TSP_NP ._SENT According_VBG to_TO the_DT bystander_NN damage_NN hypothesis_NN ,_, the_DT inflammatory_JJ and_CC neurotoxic_JJ cytokines_NNS TNF-alpha_NP and_CC IFN-gamma_NP could_MD cause_VB the_DT nonspecific_JJ cell_NN death_NN and_CC inflammation_NN seen_VBN in_IN HAM/TSP_NP patients_NNS ._SENT In_IN this_DT study_NN ,_, we_PP tested_VBD the_DT hypotheses_NNS that_IN (_( i_NP )_) HAM/TSP_NP patients_NNS and_CC ACs_NNS with_IN similar_JJ proviral_JJ loads_NNS would_MD differ_VB in_IN the_DT frequencies_NNS of_IN TNF-alpha-_NP and_CC IL-2-secreting_NP HTLV-1-specific_NP CD4+_NP T_NN cells_NNS and_CC (_( ii_NNS )_) there_EX is_VBZ a_DT correlation_NN between_IN the_DT proviral_JJ load_NN and_CC the_DT frequency_NN of_IN Th1-type_NP CD4+_NP T_NN cells_NNS in_IN either_DT HAM/TSP_NP patients_NNS or_CC ACs_NNS ._SENT We_PP therefore_RB used_VBD a_DT flow_NN cytometric_JJ assay_NN with_IN intracellular_JJ cytokine_NN staining_VBG to_TO detect_VB IFN-gamma-_NP ,_, TNF-alpha-_NP ,_, and_CC IL-2-positive_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS ._SENT The_DT cells_NNS were_VBD stimulated_VBN with_IN overlapping_JJ peptides_NNS (_( 20_CD amino_NN acids_NNS ,_, overlapping_VBG by_IN 14_CD or_CC 15_CD )_) corresponding_VBG to_TO all_DT of_IN the_DT major_JJ proteins_NNS of_IN HTLV-1_NP ._SENT Peptides_NNS were_VBD grouped_VBN into_IN one_CD pool_NN and_CC added_VBD to_TO cell_NN culture_NN medium_NN to_TO achieve_VB a_DT final_JJ concentration_NN of_IN 1_CD mug_NN of_IN each_DT peptide_NN per_IN ml_NN prior_RB to_TO incubation_NN at_IN 37C_JJ ._SENT This_DT strategy_NN should_MD detect_VB the_DT total_JJ T-helper_NN type_NN 1_CD response_NN to_TO all_DT potential_JJ epitopes_NNS of_IN HTLV-1_NP ._SENT We_PP studied_VBD HTLV-1-infected_NP ACs_NP and_CC patients_NNS with_IN HAM/TSP_NP attending_VBG the_DT HTLV-1_JJ clinic_NN at_IN St._NP Mary_NP 's_POS Hospital_NP ,_, London_NP ,_, England_NP ._SENT The_DT diagnosis_NN of_IN HAM/TSP_NP was_VBD made_VBN in_IN accordance_NN with_IN World_NP Health_NP Organization_NP criteria_NNS ._SENT Control_NN samples_NNS were_VBD obtained_VBN from_IN healthy_JJ volunteers_NNS in_IN our_PP$ laboratory_NN ._SENT Peripheral_JJ blood_NN mononuclear_JJ cells_NNS (_( PBMCs_NP )_) were_VBD isolated_VBN by_IN standard_JJ density_NN gradient_JJ centrifugation_NN and_CC cryopreserved_JJ until_IN use_NN ._SENT Nonspecific_JJ cytokine_NN production_NN by_IN PBMCs_NP was_VBD induced_VBN by_IN a_DT combination_NN of_IN 0.1_CD ng_NNS of_IN phorbol_NN myristate_NN acetate_NN (_( PMA_NN )_) per_IN ml_NN (_( Sigma_NP )_) and_CC 0.5_CD mug_NN of_IN A23187_JJ (_( Sigma_NP )_) per_IN ml_NN ,_, or_CC Staphylococcus_NP enterotoxin_NP B_NP (_( SEB_NP )_) at_IN 5_CD mug/ml_NN was_VBD added_VBN to_TO the_DT culture_NN medium_NN ._SENT Twenty_CD nanomolar_NN concanamycin_NN A_DT (_( a_DT potent_JJ inhibitor_NN of_IN perforin_NN activity_NN )_) was_VBD added_VBN to_TO the_DT culture_NN medium_NN to_TO prevent_VB CTL-mediated_JJ lysis_NN via_IN the_DT perforin-dependent_JJ cytotoxic_JJ pathway_NN ._SENT Ten_CD micrograms_NNS of_IN brefeldin_NP A_NP (_( Sigma_NP )_) per_IN ml_NN was_VBD added_VBN for_IN the_DT last_JJ 5_CD h_NN of_IN culture_NN to_TO inhibit_VB protein_NN secretion_NN ._SENT HTLV-1_NP DNA_NP was_VBD quantified_VBN by_IN real-time_JJ PCR_NP with_IN a_DT LightCycler_NP (_( Roche_NP ,_, Mannheim_NP ,_, Germany_NP )_) ._SENT HTLV-1_JJ primers_NNS SK43_NP and_CC SK44_NP were_VBD used_VBN ._SENT The_DT beta-globin_NN copy_NN number_NN of_IN each_DT sample_NN was_VBD similarly_RB quantified_VBN with_IN primers_NNS PC03_NP and_CC PC04_NP ._SENT Standard_JJ curves_NNS were_VBD generated_VBN for_IN both_DT PCRs_NN with_IN genomic_JJ DNA_NN from_IN C10-PBL_NP cells_NNS ,_, which_WDT contain_VBP one_CD Tax_NN copy_NN per_IN cell_NN ._SENT We_PP have_VBP previously_RB published_VBN data_NNS on_IN the_DT flow_NN cytometric_JJ detection_NN of_IN IFN-gamma-positive_NP ,_, CD4+_NP T_NN cells_NNS in_IN HTLV-1-infected_JJ patients_NNS ._SENT We_PP established_VBD that_IN our_PP$ 6-h_JJ flow_NN cytometric_JJ assay_NN could_MD also_RB be_VB used_VBN to_TO detect_VB the_DT cytokines_NNS TNF-alpha_NP ,_, TNF-beta_NP (_( lymphotoxin_NP )_) ,_, and_CC IL-2_NP ._SENT As_IN positive_JJ controls_NNS ,_, we_PP used_VBD the_DT nonspecific_JJ T-cell_NN stimulators_NNS PMA-A23187_JJ and_CC SEB_NP ._SENT Figure_NN illustrates_VBZ the_DT cytokine_NN characterization_NN of_IN CD4+_NP T_NN cells_NNS after_IN 6_CD and_CC 18_CD h_NN of_IN in_IN vitro_NN culture_NN with_IN brefeldin_NN A_DT inhibition_NN of_IN protein_NN secretion_NN ._SENT The_DT results_NNS showed_VBD that_IN IFN-gamma_NP ,_, TNF-alpha_NP ,_, and_CC IL-2_JJ protein_NN expression_NN could_MD be_VB detected_VBN after_IN 6_CD h._NP TNF-beta_NP was_VBD only_RB detectable_JJ after_IN 18_CD h_NN of_IN culture_NN and_CC only_RB from_IN a_DT small_JJ percentage_NN of_IN CD4+_NP T_NN cells_NNS ._SENT Isotype_NN controls_NNS showed_VBD that_IN the_DT staining_VBG was_VBD specific_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT Similar_JJ data_NNS were_VBD obtained_VBN from_IN three_CD uninfected_JJ controls_NNS ,_, two_CD HAM/TSP_NP patients_NNS ,_, and_CC two_CD ACs_NNS ._SENT We_PP applied_VBD the_DT 6-h_JJ assay_NN to_TO our_PP$ cohort_NN of_IN HAM/TSP_NP patients_NNS and_CC ACs_NNS with_IN similar_JJ proviral_JJ loads_NNS ._SENT We_PP initially_RB also_RB stained_VBN for_IN TNF-beta-positive_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN two_CD HAM/TSP_NP patients_NNS (_( TAQ_NP and_CC TAL_NP )_) and_CC two_CD ACs_NNS (_( HT_NP and_CC HBI_NP )_) but_CC did_VBD not_RB detect_VB any_DT positive_JJ cells_NNS ._SENT We_PP therefore_RB focused_VBD only_RB on_IN TNF-alpha_NP and_CC IL-2_NP staining_VBG for_IN the_DT other_JJ seven_CD subjects_NNS in_IN each_DT group_NN ._SENT Figure_NN shows_VBZ the_DT flow_NN cytometric_JJ data_NNS from_IN a_DT representative_JJ HAM/TSP_NP patient_NN (_( TBO_NP )_) ._SENT We_PP characterized_VBD the_DT cytokine_NN expression_NN of_IN HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN nine_CD HAM/TSP_NP patients_NNS and_CC nine_CD ACs_NNS with_IN similar_JJ proviral_JJ loads_NNS ._SENT The_DT data_NNS show_VBP that_IN there_EX were_VBD large_JJ populations_NNS of_IN hitherto_RB undetected_JJ TNF-alpha-_NP and_CC IL-2-positive_NP CD4+_NP T_NN cells_NNS that_WDT are_VBP HTLV-1_JJ specific_NN in_IN HAM/TSP_NP patients_NNS but_CC not_RB in_IN ACs_NP ._SENT The_DT differences_NNS were_VBD statistically_RB significant_JJ for_IN all_DT three_CD cytokines_NNS (_( IFN-gamma_NP ,_, P_NN =_SYM 0.0003_CD ;_: TNF-alpha_NP ,_, P_NN =_SYM 0.00056_CD ;_: IL-2_NP ,_, P_NN =_SYM 0.0003_CD [_SYM Mann-Whitney_NP ,_, two-tailed_JJ P_NN values_NNS ]_SYM )_) ._SENT There_EX were_VBD also_RB small_JJ numbers_NNS of_IN cells_NNS that_WDT coexpressed_VBD two_CD cytokines_NNS ,_, but_CC consistent_JJ with_IN previous_JJ reports_NNS ,_, these_DT were_VBD much_RB less_RBR frequent_JJ than_IN single-cytokine_JJ expression_NN in_IN the_DT one_CD cell_NN ._SENT Triple-cytokine_NN secretors_NNS were_VBD not_RB tested_VBN for_IN ,_, but_CC these_DT would_MD be_VB expected_VBN to_TO be_VB even_RB less_RBR common_JJ ._SENT We_PP tested_VBD for_IN correlations_NNS between_IN individual_JJ cytokines_NNS and_CC proviral_JJ loads_NNS in_IN both_DT HAM/TSP_NP subjects_NNS and_CC ACs_NNS by_IN nonparametric_JJ statistical_JJ analysis_NN (_( Spearman_NP rank_NN correlation_NN )_) ._SENT The_DT data_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT There_EX was_VBD a_DT significant_JJ correlation_NN between_IN the_DT frequency_NN of_IN total_JJ IL-2-positive_NP HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN ACs_NP and_CC the_DT proviral_JJ load_NN (_( two-tailed_JJ P_NN =_SYM 0.0138_CD ,_, r_NN =_SYM 0.8000_CD )_) ._SENT There_EX was_VBD a_DT tendency_NN to_TO a_DT positive_JJ correlation_NN between_IN proviral_JJ load_NN and_CC both_DT IFN-gamma_NP and_CC TNF-alpha_NP in_IN the_DT ACs_NP ,_, but_CC this_DT did_VBD not_RB reach_VB statistical_JJ significance_NN ._SENT The_DT data_NNS on_IN HAM/TSP_NP patients_NNS showed_VBD no_DT significant_JJ correlation_NN between_IN the_DT proviral_JJ load_NN and_CC the_DT specific-cytokine_JJ frequency_NN for_IN the_DT three_CD cytokines_NNS tested_VBD ._SENT The_DT analysis_NN of_IN T-cell_NN responses_NNS with_IN a_DT single_JJ cytokine_NN such_JJ as_IN IFN-gamma_NP may_MD not_RB be_VB representative_JJ of_IN the_DT entire_JJ Th1-type_NP response_NN ._SENT This_DT may_MD account_VB for_IN the_DT conflicting_JJ reports_NNS of_IN correlation_NN and_CC noncorrelation_NN between_IN antigen_NN loads_NNS and_CC cytokine_NN responses_NNS ,_, particularly_RB for_IN HIV_NP ._SENT We_PP therefore_RB estimated_VBD the_DT total_JJ frequency_NN of_IN Th1-type_NP HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN these_DT subjects_NNS and_CC tested_VBN for_IN a_DT correlation_NN with_IN proviral_JJ load_NN ;_: the_DT data_NNS are_VBP shown_VBN in_IN Fig._NN ._SENT We_PP show_VBP that_IN the_DT estimated_JJ total_JJ frequency_NN did_VBD not_RB correlate_VB with_IN the_DT proviral_JJ load_NN in_IN HAM/TSP_NP patients_NNS but_CC there_EX was_VBD a_DT significant_JJ positive_JJ correlation_NN in_IN ACs_NP (_( HAM/TSP_NP patients_NNS ,_, two-tailed_JJ P_NN =_SYM 0.3853_CD ,_, r_NN =_SYM 0.3264_CD ;_: ACs_NP ,_, two-tailed_JJ P_NN =_SYM 0.0214_CD ,_, r_NN =_SYM 0.7615_CD )_) ._SENT The_DT proviral_JJ load_NN in_IN HTLV-1_JJ infection_NN has_VBZ been_VBN shown_VBN to_TO correlate_VB with_IN the_DT risk_NN of_IN inflammatory_JJ diseases_NNS such_JJ as_IN HAM/TSP_NP ._SENT There_EX is_VBZ typically_RB a_DT strong_JJ CTL_NP response_NN to_TO the_DT virus_NN in_IN both_DT HAM/TSP_NP patients_NNS and_CC ACs_NNS ._SENT The_DT CTL_NP response_NN has_VBZ been_VBN shown_VBN to_TO exert_VB significant_JJ selection_NN pressure_NN on_IN the_DT Tax_NP protein_NN in_IN ACs_NP but_CC not_RB in_IN HAM/TSP_NP patients_NNS ._SENT Recent_JJ work_NN has_VBZ suggested_VBN that_IN CTLs_NP exert_VB a_DT beneficial_JJ effect_NN by_IN lightening_VBG the_DT proviral_JJ load_NN and_CC protecting_VBG against_IN HAM/TSP_NP ._SENT However_RB ,_, there_EX is_VBZ also_RB evidence_NN that_IN CTLs_NNS contribute_VBP to_TO the_DT inflammation_NN seen_VBN in_IN HAM/TSP_NP ._SENT HTLV-1-specific_JJ CTLs_NNS are_VBP found_VBN at_IN higher_JJR frequency_NN in_IN cerebrospinal_JJ fluid_NN than_IN in_IN peripheral_JJ blood_NN ,_, implying_VBG either_RB that_IN they_PP preferentially_RB migrate_VB into_IN the_DT CNS_NP or_CC that_IN they_PP selectively_RB expand_VB in_IN the_DT CNS_NP (_( or_CC both_DT )_) ._SENT Also_RB ,_, some_DT of_IN these_DT clones_NNS secrete_VBP inflammatory_JJ cytokines_NNS ,_, chemokines_NNS ,_, and_CC matrix_NN metalloproteinases_NNS ._SENT It_PP is_VBZ possible_JJ to_TO reconcile_VB these_DT apparently_RB contradictory_JJ data_NNS with_IN the_DT concept_NN of_IN a_DT threshold_NN proviral_JJ load_NN ._SENT In_IN this_DT model_NN ,_, in_IN an_DT individual_NN with_IN a_DT proviral_JJ load_NN below_IN the_DT threshold_NN ,_, sufficient_JJ T-cell_NN receptors_NNS on_IN HTLV-1-specific_JJ CTLs_NNS are_VBP engaged_VBN to_TO ensure_VB efficient_JJ cell_NN killing_VBG (_( protective_JJ )_) but_CC insufficient_JJ to_TO elicit_VB production_NN of_IN inflammatory_JJ cytokines_NNS such_JJ as_IN TNF-alpha_NP and_CC IFN-gamma_NP ._SENT As_IN the_DT proviral_JJ load_NN increases_NNS ,_, specific_JJ CTLs_NNS commence_VBP cytokine_JJ production_NN ,_, in_IN addition_NN to_TO their_PP$ cytotoxic_JJ function_NN (_( which_WDT itself_PP may_MD be_VB pathogenic_JJ as_RB well_RB as_RB protective_JJ )_) ._SENT Indeed_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_IN above_IN a_DT threshold_NN proviral_JJ load_NN of_IN similar1_JJ %_NN of_IN PBMCs_NP ,_, the_DT risk_NN of_IN HAM/TSP_NP rises_VBZ exponentially_RB ._SENT However_RB ,_, in_IN acquired_VBN immunity_NN ,_, the_DT CD4+_NP T-helper_NN cell_NN also_RB plays_VBZ a_DT critical_JJ role_NN in_IN the_DT immune_JJ response_NN ._SENT In_IN HTLV-1_NP ,_, little_RB is_VBZ known_VBN about_IN the_DT role_NN of_IN the_DT CD4+_NP T-helper_NN cell_NN ._SENT In_IN this_DT study_NN ,_, we_PP used_VBD overlapping_JJ peptide_NN libraries_NNS of_IN all_DT major_JJ HTLV-1_JJ proteins_NNS to_TO quantify_VB the_DT Th1_NP CD4+_NP T-cell_NN response_NN to_TO the_DT virus_NN in_IN both_DT HAM/TSP_NP patients_NNS and_CC infected_JJ ACs_NNS ._SENT Production_NN of_IN IFN-gamma_NP is_VBZ frequently_RB used_VBN as_IN a_DT marker_NN of_IN Th1_NP CD4+_NP T_NN cells_NNS in_IN ELISpot_NN or_CC intracellular_JJ cytokine_NN staining_VBG assays_NNS ._SENT However_RB ,_, certain_JJ Th1_JJ cells_NNS produce_VBP IL-2_NP or_CC TNF-alpha_NP but_CC not_RB IFN-gamma_NP ._SENT Previously_RB ,_, we_PP showed_VBD that_IN HAM/TSP_NP patients_NNS have_VBP a_DT predominance_NN of_IN Th1-type_NP HTLV-1-specific_NP CD4+_NP T_NN cells_NNS ._SENT In_IN this_DT study_NN ,_, we_PP wished_VBD to_TO determine_VB whether_IN there_EX are_VBP similarly_RB large_JJ populations_NNS of_IN other_JJ Th1-type_NP cytokine_NN (_( TNF-alpha_NP ,_, TNF-beta_NP ,_, and_CC IL-2)-secreting_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN HAM/TSP_NP patients_NNS compared_VBN to_TO ACs_NNS with_IN similar_JJ proviral_JJ loads_NNS ._SENT These_DT cytokines_NNS may_MD play_VB an_DT important_JJ role_NN both_CC in_IN the_DT immune_JJ response_NN to_TO HTLV-1_NP and_CC in_IN the_DT pathogenesis_NN of_IN inflammatory_JJ neurological_JJ disease_NN ._SENT A_DT heavy_JJ proviral_JJ load_NN has_VBZ been_VBN shown_VBN to_TO be_VB associated_VBN with_IN increased_VBN risk_NN and_CC severity_NN of_IN HAM/TSP_NP ._SENT Therefore_RB ,_, to_TO elucidate_VB a_DT potential_JJ mechanism_NN of_IN pathogenesis_NN of_IN HAM/TSP_NP ,_, we_PP selected_VBD a_DT group_NN of_IN patients_NNS and_CC HTLV-1-infected_JJ ACs_NNS with_IN similar_JJ loads_NNS so_RB that_IN any_DT observed_JJ differences_NNS would_MD not_RB reflect_VB proviral_JJ load_NN differences_NNS ._SENT We_PP show_VBP that_IN total_JJ TNF-alpha-_NP and_CC IL-2-positive_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS were_VBD significantly_RB more_RBR frequent_JJ in_IN HAM/TSP_NP patients_NNS than_IN in_IN ACs_NP ._SENT TNF-alpha_NP is_VBZ a_DT powerful_JJ proinflammatory_JJ cytokine_NN and_CC has_VBZ been_VBN implicated_VBN in_IN many_JJ inflammatory_JJ disorders_NNS ._SENT It_PP also_RB plays_VBZ a_DT central_JJ role_NN in_IN coordination_NN of_IN the_DT inflammatory_JJ response_NN ._SENT The_DT discovery_NN of_IN numerous_JJ TNF-alpha+_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN patients_NNS with_IN inflammatory_JJ CNS_NP disease_NN ,_, but_CC not_RB in_IN ACs_NP ,_, supports_VBZ the_DT hypothesis_NN that_IN bystander_NN damage_NN is_VBZ inflicted_VBN by_IN invading_VBG CD4+_NP T_NN cells_NNS in_IN the_DT early_JJ ,_, active_JJ lesions_NNS of_IN HAM/TSP_NP ._SENT IL-2_NP has_VBZ an_DT important_JJ role_NN in_IN lymphocyte_NN proliferation_NN and_CC in_IN arming_VBG effector_NN T_NN cells_NNS ,_, including_VBG both_DT T-helper_NN cells_NNS and_CC CTLs_NNS ._SENT IL-2_NP has_VBZ also_RB recently_RB been_VBN shown_VBN to_TO rescue_VB secondary_JJ expansion_NN and_CC function_NN in_IN CTLs_NNS depleted_VBN of_IN CD4+_NP T-cell_NN help_NN ._SENT The_DT high_JJ frequency_NN of_IN IFN-gamma+_NP ,_, TNF-alpha+_NP ,_, and_CC IL-2+_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS raises_VBZ the_DT possibility_NN that_IN such_JJ cells_NNS contribute_VBP to_TO the_DT pathogenesis_NN of_IN inflammatory_JJ CNS_NP disease_NN by_IN forming_VBG self-perpetuating_JJ inflammatory_JJ lesions_NNS ._SENT The_DT observation_NN that_IN these_DT cells_NNS are_VBP found_VBN in_IN abundance_NN in_IN patients_NNS with_IN HAM/TSP_NP but_CC not_RB in_IN ACs_NP with_IN similarly_RB high_JJ proviral_JJ loads_NNS suggests_VBZ that_IN the_DT high_JJ Th1-cell_NN frequency_NN is_VBZ specifically_RB associated_VBN with_IN the_DT disease_NN HAM/TSP_NP ._SENT Analyses_NNS of_IN total_JJ IFN-gamma-positive_JJ ,_, virus-specific_JJ T_NN cells_NNS have_VBP been_VBN reported_VBN in_IN several_JJ articles_NNS ._SENT Our_PP$ results_NNS show_VBP that_IN other_JJ Th1_JJ cytokines_NNS also_RB need_VBP to_TO be_VB examined_VBN if_IN a_DT more_RBR complete_JJ picture_NN of_IN CD4+_NP T-helper_NN responses_NNS in_IN other_JJ chronic_JJ infections_NNS with_IN viruses_NNS such_JJ as_IN HIV_NP ,_, cytomegalovirus_NN ,_, Epstein-Barr_NP virus_NN ,_, and_CC hepatitis_NP B_NP or_CC C_NP virus_NN is_VBZ to_TO be_VB obtained_VBN ._SENT Similarly_RB ,_, detection_NN of_IN IFN-gamma_NP alone_RB may_MD give_VB an_DT incomplete_JJ measure_NN of_IN virus-specific_JJ CD8+_NP T-cell_NN frequency_NN ._SENT We_PP observed_VBD positive_JJ correlations_NNS between_IN the_DT estimated_JJ total_JJ Th1_NN (_( and_CC total_JJ IL-2-positive_NN )_) CD4+_NP T-cell_NN frequencies_NNS and_CC the_DT proviral_JJ load_NN in_IN ACs_NP but_CC not_RB in_IN HAM/TSP_NP patients_NNS ._SENT There_EX are_VBP several_JJ interesting_JJ implications_NNS ._SENT The_DT frequency_NN of_IN the_DT Th1_JJ response_NN rises_NNS as_IN the_DT proviral_JJ load_NN increases_NNS in_IN ACs_NP but_CC not_RB in_IN HAM/TSP_NP patients_NNS ._SENT Yet_RB the_DT proviral_JJ loads_NNS are_VBP not_RB dissimilar_JJ between_IN the_DT two_CD groups_NNS ._SENT This_DT suggests_VBZ that_IN there_EX are_VBP fundamental_JJ qualitative_JJ (_( functional_JJ )_) ,_, as_RB well_RB as_IN quantitative_JJ ,_, differences_NNS in_IN the_DT CD4+_NP T-cell_NN response_NN to_TO HTLV-1_NP ._SENT What_WP might_MD such_JJ qualitative_JJ differences_NNS be_VB ?_SENT It_PP is_VBZ not_RB possible_JJ to_TO reach_VB a_DT robust_JJ conclusion_NN about_IN the_DT efficiency_NN or_CC effectiveness_NN of_IN the_DT antiviral_JJ T-cell_NN response_NN from_IN the_DT frequency_NN of_IN such_JJ cells_NNS in_IN the_DT circulation_NN ._SENT However_RB ,_, the_DT greater_JJR frequency_NN of_IN HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN patients_NNS with_IN HAM/TSP_NP and_CC a_DT given_VBN proviral_JJ load_NN implies_VBZ either_RB that_IN their_PP$ CD4+_NP T_NN cells_NNS proliferate_VBP faster_RBR (_( or_CC die_VB more_RBR slowly_RB )_) than_IN those_DT of_IN ACs_NP or_CC that_DT more_JJR HTLV-1_NP antigen_NN is_VBZ expressed_VBN in_IN HAM/TSP_NP patients_NNS than_IN in_IN ACs_NP with_IN a_DT similar_JJ proviral_JJ load_NN (_( or_CC both_DT )_) ._SENT In_IN conclusion_NN ,_, we_PP show_VBP here_RB that_IN there_EX are_VBP significantly_RB higher_JJR frequencies_NNS of_IN TNF-alpha-_NP and_CC IL-2-positive_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS in_IN HAM/TSP_NP patients_NNS than_IN in_IN HTLV-1-infected_NP ACs_NP with_IN similar_JJ proviral_JJ loads_NNS ._SENT These_DT results_NNS confirm_VBP and_CC extend_VBP our_PP$ previous_JJ work_NN on_IN IFN-gamma-positive_NP ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS with_IN another_DT assay_NN ._SENT The_DT relative_JJ importance_NN of_IN these_DT three_CD cytokines_NNS in_IN the_DT pathogenesis_NN of_IN HAM/TSP_NP is_VBZ unknown_JJ ._SENT There_EX were_VBD positive_JJ correlations_NNS between_IN the_DT estimated_JJ total_JJ Th1_NN (_( and_CC total_JJ IL-2_JJ response_NN )_) and_CC proviral_JJ load_NN in_IN ACs_NP but_CC not_RB in_IN patients_NNS with_IN HAM/TSP_NP ._SENT The_DT data_NNS suggest_VBP that_IN there_EX are_VBP quantitative_JJ and_CC qualitative_JJ differences_NNS in_IN the_DT T-helper_NN cell_NN populations_NNS between_IN HAM/TSP_NP patients_NNS and_CC ACs_NNS ._SENT We_PP have_VBP preliminary_JJ evidence_NN that_IN the_DT HTLV-1_JJ antigens_NNS recognized_VBN by_IN CD4+_NP T_NN cells_NNS in_IN HAM/TSP_NP patients_NNS and_CC ACs_NNS do_VBP not_RB differ_VB (_( unpublished_JJ data_NNS )_) ;_: however_RB ,_, it_PP remains_VBZ possible_JJ that_IN the_DT epitopes_NNS within_IN these_DT antigens_NNS differ_VBP systematically_RB ._SENT The_DT data_NNS presented_VBN in_IN this_DT report_NN have_VBP important_JJ implications_NNS for_IN the_DT understanding_NN of_IN the_DT pathogenesis_NN of_IN HAM/TSP_NP disease_NN ,_, the_DT cellular_JJ immune_JJ response_NN to_TO HTLV-1_NP ,_, and_CC possible_JJ therapeutic_JJ approaches_NNS ._SENT Th1-type_NN cytokine_NN functional_JJ characterization_NN of_IN CD4+_NP T_NN cells_NNS ._SENT Th1-type_NN cytokine_NN functional_JJ characterization_NN of_IN CD4+_NP T_NN cells_NNS ._SENT Staining_VBG for_IN intracellular_JJ IFN-gamma_NP ,_, TNF-alpha_NP ,_, TNF-beta_NP ,_, and_CC IL-2_NP was_VBD conducted_VBN following_VBG stimulation_NN with_IN SEB_NP or_CC with_IN PMA_NN and_CC A23187_JJ (_( a_DT calcium_NN ionophore_NN )_) for_IN 6_CD or_CC 18_CD h_NN of_IN in_IN vitro_NN culture_NN of_IN PBMCs_NP ._SENT Brefeldin_NP A_NP was_VBD added_VBN for_IN the_DT last_JJ 5_CD h_NN to_TO inhibit_VB protein_NN secretion_NN ._SENT TNF-beta_NP was_VBD only_RB detected_VBN after_IN 18_CD h_NN of_IN culture_NN and_CC only_RB at_IN a_DT low_JJ frequency_NN ._SENT Cells_NNS were_VBD gated_VBN on_IN the_DT CD4hi_NP population_NN for_IN SEB_NP stimulation_NN and_CC controls_NNS or_CC on_IN all_DT lymphocytes_NNS for_IN PMA_NN stimulation_NN ._SENT High_JJ frequencies_NNS of_IN TNF-alpha-_NP and_CC IL-2-positive_NP CD4+_NP T_NN cells_NNS in_IN HAM/TSP_NP patients_NNS after_IN 6_CD h_NN of_IN in_IN vitro_NN culture_NN with_IN HTLV-1_JJ peptides_NNS ._SENT High_JJ frequencies_NNS of_IN TNF-alpha-_NP and_CC IL-2-positive_NP CD4+_NP T_NN cells_NNS in_IN HAM/TSP_NP patients_NNS after_IN 6_CD h_NN of_IN in_IN vitro_NN culture_NN with_IN HTLV-1_JJ peptides_NNS ._SENT Data_NNS on_IN TBO_NP ,_, a_DT patient_NN with_IN HAM/TSP_NP ,_, are_VBP shown_VBN ._SENT Cells_NNS were_VBD gated_VBN on_IN the_DT CD4hi_NP population_NN ._SENT The_DT total_JJ number_NN of_IN events_NNS collected_VBN was_VBD 200,000_CD for_IN the_DT peptide-stimulated_JJ culture_NN and_CC 100,000_CD for_IN the_DT control_NN (_( no_DT peptides_NNS )_) ._SENT Correlation_NN between_IN frequency_NN of_IN single-cytokine-positive_NN ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS and_CC proviral_JJ load_NN (_( PL_NP )_) ._SENT Correlation_NN between_IN frequency_NN of_IN single-cytokine-positive_NN ,_, HTLV-1-specific_NP CD4+_NP T_NN cells_NNS and_CC proviral_JJ load_NN (_( PL_NP )_) ._SENT There_EX is_VBZ a_DT significant_JJ positive_JJ correlation_NN between_IN IL-2-positive_NP HTLV-1-specific_NP CD4+_NP T-cell_NN frequency_NN and_CC proviral_JJ load_NN in_IN ACs_NP ._SENT There_EX is_VBZ a_DT trend_NN toward_IN a_DT positive_JJ correlation_NN for_IN all_DT three_CD cytokines_NNS in_IN ACs_NP ,_, but_CC this_DT does_VBZ not_RB reach_VB significance_NN for_IN IFN-gamma_NP and_CC TNF-alpha_NP ._SENT Data_NNS were_VBD analyzed_VBN by_IN Spearman_NP rank_JJ correlation_NN ._SENT The_DT solid_JJ line_NN represents_VBZ a_DT least-squares_NNS regression_NN line_NN ._SENT The_DT asterisk_NN indicates_VBZ a_DT significant_JJ correlation_NN ._SENT Correlation_NN between_IN total_JJ Th1-type_NP ,_, HTLV-1-specific_NP CD4+_NP T-cell_NN frequency_NN and_CC proviral_JJ load_NN ._SENT Correlation_NN between_IN total_JJ Th1-type_NP ,_, HTLV-1-specific_NP CD4+_NP T-cell_NN frequency_NN and_CC proviral_JJ load_NN ._SENT The_DT total_JJ Th1_JJ frequency_NN correlates_NNS positively_RB with_IN the_DT proviral_JJ load_NN in_IN ACs_NP but_CC not_RB in_IN HAM/TSP_NP patients_NNS ._SENT Analysis_NN was_VBD done_VBN by_IN Spearman_NP rank_JJ correlation_NN ._SENT The_DT solid_JJ line_NN represents_VBZ a_DT least-squares_NNS regression_NN line_NN ._SENT The_DT asterisk_NN indicates_VBZ a_DT significant_JJ correlation_NN ._SENT HTLV-specific_NP CD4+_NP T-cell_NN frequencies_NNS in_IN HTLV-1-infected_JJ subjects_NNS 